

HY-147266 · 1 mg
MedChemExpress · Cat: HY-147266
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/elebsiran.html
Description
Elebsiran VIR-2218 sodium is a siRNA that targets and degrades hepatitis B virus HBV and hepatitis D virus HDV RNA transcripts. Elebsiran sodium leads to a significant decrease in HBV surface antigen HBsAg and a reduction in viral load. Elebsiran sodium binds to the sialic acid-depleted glycoprotein receptor ASGPR on the surface of liver cells through the GalNAc ligand, achieving liver-targeted delivery and demonstrating improved liver safety. Elebsiran sodium can be used for the study of chronic HBV/HDV infections.







